Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A “Click Chemistry Platform” for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation
Ryan P. Wurz, Ken Dellamaggiore, Hannah Dou, et al.
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 2, pp. 453-461
Closed Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 467
Bromodomains: a new target class for drug development
Andrea G. Cochran, Andrew R. Conery, Robert J. Sims
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 8, pp. 609-628
Closed Access | Times Cited: 375
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li, Yongcheng Song
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 327
Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
Scott D. Edmondson, Bin Yang, Charlene Fallan
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 13, pp. 1555-1564
Closed Access | Times Cited: 316
Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Kristin M. Riching, Sarah D. Mahan, Cesear Corona, et al.
ACS Chemical Biology (2018) Vol. 13, Iss. 9, pp. 2758-2770
Open Access | Times Cited: 263
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem, Craig M. Crews
Chemical Reviews (2017) Vol. 117, Iss. 17, pp. 11269-11301
Closed Access | Times Cited: 255
Degradation of proteins by PROTACs and other strategies
Yang Wang, Xueyang Jiang, Feng Feng, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 2, pp. 207-238
Open Access | Times Cited: 254
Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan, Matthias G. J. Baud
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 5
Open Access | Times Cited: 249
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou, Xueyang Jiang, Siyu He, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 20, pp. 8881-8914
Closed Access | Times Cited: 235
The PROTAC technology in drug development
Yutian Zou, Danhui Ma, Yinyin Wang
Cell Biochemistry and Function (2019) Vol. 37, Iss. 1, pp. 21-30
Open Access | Times Cited: 224
Recent applications of click chemistry in drug discovery
Xiangyi Jiang, Xia Hao, Lanlan Jing, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 8, pp. 779-789
Closed Access | Times Cited: 213
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
Scott J. Hughes, Alessio Ciulli
Essays in Biochemistry (2017) Vol. 61, Iss. 5, pp. 505-516
Open Access | Times Cited: 212
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
Mikhail M. Savitski, Nico Zinn, Maria Faelth-Savitski, et al.
Cell (2018) Vol. 173, Iss. 1, pp. 260-274.e25
Open Access | Times Cited: 208
Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
Kwok-Ho Chan, Michael Zengerle, Andrea Testa, et al.
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 2, pp. 504-513
Open Access | Times Cited: 190
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Caroline M. Robb, Jacob I. Contreras, Smit Kour, et al.
Chemical Communications (2017) Vol. 53, Iss. 54, pp. 7577-7580
Open Access | Times Cited: 189
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 168
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Shenxin Zeng, Wenhai Huang, Xiaoliang Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112981-112981
Closed Access | Times Cited: 164
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
Shang Su, Zimo Yang, Hongying Gao, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 16, pp. 7575-7582
Open Access | Times Cited: 156
Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras
Troy A. Bemis, James J. La Clair, Michael D. Burkart
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8042-8052
Closed Access | Times Cited: 151
Phosphorylation-Inducing Chimeric Small Molecules
Sachini U. Siriwardena, Dhanushka N. P. Munkanatta Godage, Veronika M. Shoba, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 33, pp. 14052-14057
Closed Access | Times Cited: 138
Chemoselective Electrosynthesis Using Rapid Alternating Polarity
Yu Kawamata, Kyohei Hayashi, Ethan Carlson, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 40, pp. 16580-16588
Open Access | Times Cited: 126
From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
Carlotta Cecchini, Sara Pannilunghi, Sébastien Tardy, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 123
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
Dongwen Lv, Pratik Pal, Xingui Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 106
E3 ligase ligand chemistries: from building blocks to protein degraders
Izidor Sosič, Aleša Bricelj, Christian Steinebach
Chemical Society Reviews (2022) Vol. 51, Iss. 9, pp. 3487-3534
Closed Access | Times Cited: 92
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 73
Page 1 - Next Page

Scroll to top